Amneal Pharmaceuticals (AMRX) Enterprise Value (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Enterprise Value of -$4.7 million for Q1 2026, down 107.17% year-over-year from $66.0 million in Q1 2025, and up 98.33% quarter-over-quarter from -$282.6 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Enterprise Value (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Enterprise Value history runs 10 years deep, the most recent figure standing at -$4.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 107.17% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$4.7 million (down 107.17% YoY), while the FY2025 annual figure was -$282.6 million, down 519.96% from the prior year.
- Enterprise Value for Q1 2026 stood at -$4.7 million, up from -$282.6 million in the prior quarter.
- The five-year high for Enterprise Value was $66.0 million in Q1 2025, with the low at -$282.6 million in Q4 2025.
- The 5-year median for Enterprise Value is $10.4 million (2022), against an average of -$16.3 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value plunged 1231.64% in 2023, then soared 13052.99% in 2025.
- Amneal Pharmaceuticals' Enterprise Value stood at $15.7 million in 2022, then slumped by 420.1% to -$50.2 million in 2023, then rose by 9.3% to -$45.6 million in 2024, then slumped by 519.96% to -$282.6 million in 2025, then soared by 98.33% to -$4.7 million in 2026.
- Business Quant data shows AMRX's Enterprise Value at -$4.7 million in Q1 2026, -$282.6 million in Q4 2025, and $33.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | -43.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.68 Mn |
| Mar 31, 2026 | -4.73 Mn |
| Dec 31, 2025 | -282.56 Mn |
| Sep 30, 2025 | 33.08 Mn |
| Jun 30, 2025 | 56.16 Mn |
| Mar 31, 2025 | 66.03 Mn |
| Dec 31, 2024 | -45.58 Mn |
| Sep 30, 2024 | 55.55 Mn |
| Jun 30, 2024 | 9.65 Mn |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | -50.25 Mn |
| Sep 30, 2023 | 28.47 Mn |
| Jun 30, 2023 | -77.18 Mn |
| Mar 31, 2023 | -117.15 Mn |
| Dec 31, 2022 | 15.70 Mn |
| Sep 30, 2022 | 13.82 Mn |
| Jun 30, 2022 | 11.68 Mn |
| Mar 31, 2022 | 10.35 Mn |
| Dec 31, 2021 | 7.96 Mn |
| Sep 30, 2021 | 7.30 Mn |